These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 29034843)

  • 1. Research Progress in Reversal of Tumor Multi-drug Resistance via Natural Products.
    Guo Q; Cao H; Qi X; Li H; Ye P; Wang Z; Wang D; Sun M
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1466-1476. PubMed ID: 29034843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marine Natural Products as Models to Circumvent Multidrug Resistance.
    Long S; Sousa E; Kijjoa A; Pinto MM
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
    Karthikeyan S; Hoti SL
    Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural products as multidrug resistance modulators in cancer.
    Kumar A; Jaitak V
    Eur J Med Chem; 2019 Aug; 176():268-291. PubMed ID: 31103904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
    Kars MD; Işeri OD; Gunduz U; Molnar J
    Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marine natural products as breast cancer resistance protein inhibitors.
    Cherigo L; Lopez D; Martinez-Luis S
    Mar Drugs; 2015 Apr; 13(4):2010-29. PubMed ID: 25854646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.
    Dewanjee S; Dua TK; Bhattacharjee N; Das A; Gangopadhyay M; Khanra R; Joardar S; Riaz M; Feo V; Zia-Ul-Haq M
    Molecules; 2017 May; 22(6):. PubMed ID: 28587082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products to prevent drug resistance in cancer chemotherapy: a review.
    Yuan R; Hou Y; Sun W; Yu J; Liu X; Niu Y; Lu JJ; Chen X
    Ann N Y Acad Sci; 2017 Aug; 1401(1):19-27. PubMed ID: 28891091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
    Joshi P; Vishwakarma RA; Bharate SB
    Eur J Med Chem; 2017 Sep; 138():273-292. PubMed ID: 28675836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.
    Dinic J; Podolski-Renic A; Stankovic T; Bankovic J; Pesic M
    Curr Pharm Des; 2015; 21(38):5589-604. PubMed ID: 26429711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural product modulators to overcome multidrug resistance in cancer.
    Cort A; Ozben T
    Nutr Cancer; 2015; 67(3):411-23. PubMed ID: 25649862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant.
    Liang Y; Liu ZY; Wang PY; Li YJ; Wang RR; Xie SY
    J Control Release; 2021 Aug; 336():396-409. PubMed ID: 34175367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Targeting of Vacuolar H
    Wang Y; Zhang L; Wei Y; Huang W; Li L; Wu AA; Dastur A; Greninger P; Bray WM; Zhang CS; Li M; Lian W; Hu Z; Wang X; Liu G; Yao L; Guh JH; Chen L; Wang HR; Zhou D; Lin SC; Xu Q; Shen Y; Zhang J; Jurica MS; Benes CH; Deng X
    Cell Chem Biol; 2020 Nov; 27(11):1359-1370.e8. PubMed ID: 32649904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constituents and Anti-Multidrug Resistance Activity of
    Hung HY; Hung CC; Liang JW; Chen CF; Chen HY; Shieh PC; Kuo PC; Wu TS
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31623176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Progress on Reversing Multidrug Resistance in Tumors by Using Chinese Medicine.
    Zhao HD; Xie HJ; Li J; Ren CP; Chen YX
    Chin J Integr Med; 2018 Jun; 24(6):474-480. PubMed ID: 29860581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents.
    Ojima I; Borella CP; Wu X; Bounaud PY; Oderda CF; Sturm M; Miller ML; Chakravarty S; Chen J; Huang Q; Pera P; Brooks TA; Baer MR; Bernacki RJ
    J Med Chem; 2005 Mar; 48(6):2218-28. PubMed ID: 15771464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
    Dinić J; Podolski-Renić A; Jeremić M; Pešić M
    Curr Pharm Des; 2018; 24(36):4334-4354. PubMed ID: 30648503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Treatment by Using Traditional Chinese Medicine: Probing Active Compounds in Anti-multidrug Resistance During Drug Therapy.
    Lou JS; Yao P; Tsim KWK
    Curr Med Chem; 2018; 25(38):5128-5141. PubMed ID: 28933300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.